LicianPro

TELA Bio, Inc. ·

TELA 8-K 2026-09-29

TELA Bio, Inc. (TELA) 8-K dated 2026-09-29 — accession 0001104659-26-111920.

TELA Bio, Inc. (TELA) is a medical devices company listed on NASDAQ.

TELA Bio, Inc. filed a 8-K on 2026-09-29. Accession 0001104659-26-111920.

This 8-K covers: Material agreement (Item 1.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TELA revenue for 2025-12-31 was $80.3M. Net income was -$38.8M. Revenue was up 15.8% from 2024-12-31 to 2025-12-31. TELA currently screens at market cap $38.5M.

Not investment advice. The TELA SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr